Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: scoobypax who wrote (72870)	7/25/2001 12:38:26 PM
From: tuck	Read Replies (1) \| Respond to of 122087

Jane and Indago, This is more like it. I've heard of NTUN, but don't follow it. Interesting chart, eh? siliconinvestor.com Based on it, I'd short at $5.5, looking for low $4s. Since I whined about the lack of picks, I'd better throw in my own. Looking at EMIS, going (with Lilly) before the FDA ("Just say no to drugs") this week with Forteo for osteoporosis. Thinking of buying a straddle that is biased to the downside, but still trying to estimate approval chances. I'll update if I can find anything out on that score. If I can't get informed and it gets approved, shorting the run-up would also be worth a look as volume lightens. Edit: thinking a similar strategy would be even more effective with AVIR. Kicking myself for not shorting AMLN yesterday. C'est larvae. Cheers, Tuck